Fact CheckerSign in

NCT07482865Recruiting

Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support

Source: ClinicalTrials.gov · Last updated 23 Oct 2026

Brief summary (registry, in English)

A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion in the occurrence of sign or symptom of acute limb ischemia in patients undergoing mechanical circulatory support (MCS) through femoral artery approach.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
500 (estimated)
First submitted
15 Mar 2026
Start date
8 Jul 2026
Primary completion date
31 Aug 2030
Lead sponsor
Samsung Medical Center
NCT number
NCT07482865

What you commit to

  • Study type: Interventional
  • Planned participants: 500
  • From 8 Jul 2026 to the primary completion date, 31 Aug 2030
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Irreversible limb ischemia requiring interventional procedures or surgery at the time of MCS insertion
  • Previous history if femoral-femoral bypass grafting or femoral-popliteal bypass grafting
  • Previous history of limb amputation

Other illness

  • Significant coagulopathy precluding invasive procedure due to high risk of bleeding

Other

  • Apparent symptoms and sign of acute limb ischemia immediately after mechanical circulatory support insertion
  • Pregnant women, women with potential childbearing, or lactating women
  • Unwilling or unable to obtain informed consent from the participant or legally authorized representative

Who the study is looking for

  • Patients aged 19 years old
  • Cardiogenic shock requiring mechanical circulatory support through femoral artery approach
  • Subject who can verbally confirm understandings of risks and benefits of receiving distal perfusion catheter insertion and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
  • Under the critically-ill clinical circumstance (unclear consciousness of patient), legally authorized representative can provide written informed consent prior to any study related procedure.

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gyeongsang National University Changwon hospital
Coordinator of this site? Confirm its status
ChangwonSouth KoreaNot yet recruiting
Samsung Medical Center Changwon Hospital
Coordinator of this site? Confirm its status
ChangwonSouth KoreaNot yet recruiting
Kwandong University Intl. ST. Mary's Hospital
Coordinator of this site? Confirm its status
IncheonSouth KoreaNot yet recruiting
Eunpyeong St. Mary's Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaNot yet recruiting
Korea University Anam Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaNot yet recruiting
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.